165 related articles for article (PubMed ID: 10735894)
21. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.
Hoffmann TK; Sonkoly E; Hauser U; van Lierop A; Whiteside TL; Klussmann JP; Hafner D; Schuler P; Friebe-Hoffmann U; Scheckenbach K; Erjala K; Grénman R; Schipper J; Bier H; Balz V
Oral Oncol; 2008 Dec; 44(12):1100-9. PubMed ID: 18487078
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.
Theurer JA; Stecho W; Yoo J; Kwan K; Wehrli B; Harry V; Black M; Pinto N; Winquist E; Palma D; Richter S; Barrett JW; Danielle MacNeil S; Fung K; Howlett CJ; Nichols AC
Pathol Oncol Res; 2016 Jan; 22(1):35-40. PubMed ID: 26271341
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis.
Su YX; Zheng JW; Zheng GS; Liao GQ; Zhang ZY
Chin Med J (Engl); 2008 Oct; 121(19):1939-44. PubMed ID: 19080128
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.
Sauter ER; Ridge JA; Litwin S; Langer CJ
Clin Cancer Res; 1995 Nov; 1(11):1407-12. PubMed ID: 9815938
[TBL] [Abstract][Full Text] [Related]
25. A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium.
Grégoire V; Beauduin M; Humblet Y; Hamoir M; Longueville J; Majois F; Remacle FM; Rousseau F; Salamon E; Wambersie A
J Clin Oncol; 1991 Aug; 9(8):1385-92. PubMed ID: 2072142
[TBL] [Abstract][Full Text] [Related]
26. Expression of p53 protein in advanced head and neck squamous cell carcinoma before and after chemotherapy.
Dunphy CH; Dunphy FR; Boyd JH; Varvares MA; Kim HJ; Lowe V; Dunleavy TL; Rodriguez J; McDonough EM; Minster J
Arch Otolaryngol Head Neck Surg; 1997 Nov; 123(11):1223-5. PubMed ID: 9366702
[TBL] [Abstract][Full Text] [Related]
27. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
29. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer.
Schneider-Stock R; Mawrin C; Motsch C; Boltze C; Peters B; Hartig R; Buhtz P; Giers A; Rohrbeck A; Freigang B; Roessner A
Am J Pathol; 2004 Apr; 164(4):1233-41. PubMed ID: 15039212
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Blons H; Gad S; Zinzindohoué F; Manière I; Beauregard J; Tregouet D; Brasnu D; Beaune P; Laccourreye O; Laurent-Puig P
Clin Cancer Res; 2004 Apr; 10(8):2594-9. PubMed ID: 15102660
[TBL] [Abstract][Full Text] [Related]
31. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
[TBL] [Abstract][Full Text] [Related]
32. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
33. CCND1 amplification predicts sensitivity to chemotherapy and chemoradiotherapy in head and neck squamous cell carcinoma.
Ishiguro R; Fujii M; Yamashita T; Tashiro M; Tomita T; Ogawa K; Kameyama K
Anticancer Res; 2003; 23(6D):5213-20. PubMed ID: 14981992
[TBL] [Abstract][Full Text] [Related]
34. Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value.
Bosch FX; Ritter D; Enders C; Flechtenmacher C; Abel U; Dietz A; Hergenhahn M; Weidauer H
Int J Cancer; 2004 Sep; 111(4):530-8. PubMed ID: 15239130
[TBL] [Abstract][Full Text] [Related]
35. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
[TBL] [Abstract][Full Text] [Related]
36. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
Leng K; Schlien S; Bosch FX
J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
[TBL] [Abstract][Full Text] [Related]
37. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy prior to surgery in head and neck cancer.
Paterson C; Robertson AG; Grose D; Correa PD; Rizwanullah M
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):79-80. PubMed ID: 22070911
[No Abstract] [Full Text] [Related]
39. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
40. Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy.
Zhang H; Graham CM; Elci O; Griswold ME; Zhang X; Khan MA; Pitman K; Caudell JJ; Hamilton RD; Ganeshan B; Smith AD
Radiology; 2013 Dec; 269(3):801-9. PubMed ID: 23912620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]